Chemed (NYSE:CHE) Releases FY 2024 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 23.000-23.150 for the period, compared to the consensus estimate of 23.580. The company issued revenue guidance of -. Chemed also updated its FY24 guidance to $23.00-$23.15 EPS.

Chemed Stock Performance

Shares of CHE stock traded up $1.13 during trading on Tuesday, hitting $609.98. 94,079 shares of the company were exchanged, compared to its average volume of 83,506. The firm has a market capitalization of $9.23 billion, a price-to-earnings ratio of 32.83, a P/E/G ratio of 2.44 and a beta of 0.44. The business’s 50-day simple moving average is $586.88 and its 200 day simple moving average is $569.34. Chemed has a twelve month low of $525.36 and a twelve month high of $654.62.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were issued a dividend of $0.50 per share. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s payout ratio is currently 10.76%.

Insider Buying and Selling

In other news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the transaction, the director now owns 3,446 shares in the company, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Andrea R. Lindell sold 831 shares of the company’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $571.51, for a total transaction of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,144 shares of company stock worth $4,141,679. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.